Skip to main content

Uterine Cancer PROACTION Diagnostic Test

The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.

Contact: clinicalresearch@sutterhealth.org

John D Hoff, M.D., Ph.D.
John D Hoff, M.D., Ph.D.
Principal investigator
View profile

Related studies

View all studies
  • Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

  • A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer.

  • A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

  • Molecular Characterization of Breast Cancer with Duct Forming Features

  • Research study

    DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?